Advertisement

Intracranial Ependymoma

  • Jaipreet S. Suri
  • Paul Youn
  • Michael T. Milano
Chapter

Abstract

Ependymomas are uncommon tumors arising from the ependymal cells lining the ventricles, central canal, filum terminale, or choroid plexus. As per WHO 2016 pathologic classification, ependymal tumors can be classified as grade I (subependymoma or myxopapillary), grade II [ependymoma (with papillary, clear cell, tanycytic subtypes)], or grade III (anaplastic). Clinical presentation depends on the tumor location. Prognostic factors include extent of resection, tumor grade, age at time of diagnosis, Karnofsky performance status (KPS), tumor location, and adjuvant radiation therapy, with arguably extent of resection being the most significant factor. Predominant pattern of recurrence is local. Management of adult intracranial ependymoma remains controversial, and multi-institutional prospective trials are needed.

Keywords

Ependymoma Intracranial Adult Management Prognosis Radiation therapy Radiation dose 

References

  1. 1.
    Reni M, Gatta G, Mazza E, et al. Ependymoma. Crit Rev Oncol Hematol. 2007;63(1):81–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Asaid M, Preece P, Rosenthal M, et al. Ependymoma in adults: local experience with an uncommon tumour. J Clin Neurosci. 2015;22(9):1392–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Gilbert M, Ruda R, Soffietti R. Ependymomas in adults. Curr Neurol Neurosci Rep. 2010;10(3):240–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Ostrom Q, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neurooncology. 2015;17(Suppl 4):iv1–iv62.Google Scholar
  5. 5.
    Ghia A, Mahajan A, Allen P, et al. Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis. J Neurooncol. 2013;115(3):513–20.CrossRefPubMedGoogle Scholar
  6. 6.
    Thompson Y, Ramaswamy V, Diamandis P, et al. Posterior fossa ependymoma: current insights. Childs Nerv Syst. 2015;31(10):1699–706.CrossRefPubMedGoogle Scholar
  7. 7.
    Chamberlain M. Ependymomas. Curr Neurol Neurosci Rep. 2003;3(3):193–9.CrossRefPubMedGoogle Scholar
  8. 8.
    National Comprehensive Cancer Network. Central Nervous System Cancers (version 1.2016). https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf. Accessed 12 Apr 2017.
  9. 9.
    Halperin E, Brady L, Perez C. Perez & Brady’s principles and practice of radiation oncology. 6th ed. Philadelphia: Wolters Kluwer; 2015.Google Scholar
  10. 10.
    Constine LS, Tarbell NJ, Halperin EC. Pediatric radiation oncology, LWW. 6th ed. Philadelphia: Wolters Kluwer; 2016.Google Scholar
  11. 11.
    Schild S, Nisi K, Scheithauer B, et al. The results of radiotherapy for ependymomas: the mayo clinic experience. Int J Radiat Oncol Biol Phys. 1998;42(5):953–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Vanuytsel L, Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma intracranial ependymoma. Int J Radiat Oncol Biol Phys. 1991;21(3):825–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Louis D, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.CrossRefGoogle Scholar
  14. 14.
    Hollon T, Nguyen V, Smith B, et al. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors. J Neurosurg. 2016;125(2):410–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Kovalic J, Flaris N, Grigsby P, et al. Intracranial ependymoma long term outcome, patterns of failure. J Neurooncol. 1993;15(2):125–31.CrossRefPubMedGoogle Scholar
  16. 16.
    Vera-Bolanos E, Aldape K, Yuan Y, et al. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neurooncology. 2015;17(3):440–7.Google Scholar
  17. 17.
    Rooney J, Stauder M, Laack N. Adult supratentorial ependymoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2011;81((2):S299–300.CrossRefGoogle Scholar
  18. 18.
    Metellus P, Guyotat J, Chinot O, et al. Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neurooncology. 2010;12(9):976–84.Google Scholar
  19. 19.
    Rogers L, Pueschel J, Spetzler R, et al. Intracranial ependymomas in the adult patient: the barrow neurological institute experience. Int J Radiat Oncol Biol Phys. 2003;57(2):S371.CrossRefGoogle Scholar
  20. 20.
    Rogers L, Pueschel J, Spetzler R, et al. Is gross-total resection sufficient treatment for posterior fossa ependymomas? J Neurosurg. 2005;102(4):629–36.CrossRefPubMedGoogle Scholar
  21. 21.
    Donahue B, Steinfeld A. Intracranial ependymoma in the adult patient: successful treatment with surgery and radiotherapy. J Neurooncol. 1998;37(2):131–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Paulino A. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? Int J Radiat Oncol Biol Phys. 2001;49(3):757–61.CrossRefPubMedGoogle Scholar
  23. 23.
    Kalash R, Glaser S, Balasubramani G, et al. Adult ependymoma (AE) patients: practice patterns and overall survival. Int J Radiat Oncol Biol Phys. 2016;96(2):E90.CrossRefGoogle Scholar
  24. 24.
    Schwartz T, Kim S, Glick R, et al. Supratentorial ependymomas in adult patients. Neurosurgery. 1999;44(4):721–31.CrossRefPubMedGoogle Scholar
  25. 25.
    Stüben G, Stuschke M, Kroll M, et al. Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother Oncol. 1997;45(1):3–10.CrossRefPubMedGoogle Scholar
  26. 26.
    Reni M, Brandes A, Vavassori V, et al. A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer. 2004;100(6):1221–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Lawrence Y, Li X, el Naqa I, et al. Radiation dose–volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76(3):S20–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jaipreet S. Suri
    • 1
  • Paul Youn
    • 1
  • Michael T. Milano
    • 2
  1. 1.Department of Radiation OncologyUniversity of Rochester Medical Center/James P. Wilmot Cancer CenterRochesterUSA
  2. 2.Department of Radiation OncologyUniversity of Rochester Medical CenterRochesterUSA

Personalised recommendations